In comparison with the HDAC inhibitor treatment, the S phase ratio in the cancer cells treated by HDAC inhibitor+PI3K inhibitor was significantly decreased, and the G2/M ratio phase was significantly increased (P<0.05). This evidence concerns the gene HDAC9 and cancer.